Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.
John G. Rizk, Donald N. Forthal, Kamyar Kalantar‐Zadeh, Mandeep R. Mehra, Carl J. Lavie, Youssef Rizk, J Pfeiffer, John C. Lewin
Topics & Concepts
Compassionate UsePandemicExpanded accessMedicineCoronavirus disease 2019 (COVID-19)HydroxychloroquineClinical trialAuthorizationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineDrugCoronavirusVirologyInfectious disease (medical specialty)PharmacologyDiseaseComputer securityOncologyInternal medicineComputer scienceBiomedical Ethics and RegulationPharmaceutical studies and practicesLong-Term Effects of COVID-19